Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line

Fig. 2

A Kaplan -Meier curves for PFS and OS were used to determine 1.1%, 0.65% 0.8%, and 0,7 as the cut-off of CD137+, CD137+ PD1+, CD137+CD8+, and CD8+CD137+ PD1+ T cells, respectively. Long-rack test was used to analyze the differences between the two groups. m = months, p values < 0.05 were considered significant

Back to article page